SPARK THERAPEUTICS, INC.

Ajouter à une liste

Instrument Inactif

Communiqués Spark Therapeutics, Inc.

Actions

US84652J1034

Recherche biotechnologique et médicale

Communiqués

30/01/23	Spark Therapeutics Enters Into Strategic Collaboration with Neurochase for Use of Proprietary Delivery Technology for CNS Disorders	AQ
20/12/21	Spark Therapeutics to Invest $575M in New 500k Square Foot State-of-the-Art Gene Therapy Innovation Center on Drexel's University City Campus	AQ
18/11/21	University of Pennsylvania : Novel gene therapy for hemophilia A	AQ
08/02/21	Spark Therapeutics : Announces Preliminary Data from Phase 1/2 Clinical Trial of SPK-8016 in Hemophilia A at EAHAD 2021 Virtual Congress	AQ
17/11/20	Spark Therapeutics : Expands Visionary Leadership with Appointment of Michael Retterath as Chief Strategy Officer	AQ
04/08/20	Spark Therapeutics : Recognized for Fourth-straight Year as One of Philadelphia's 'Best Places to Work' by the Philadelphia Business Journal	AQ
02/06/20	Spark Therapeutics : Study Demonstrating Role of IdeS in Enabling of Gene Therapy in the Presence of Neutralizing Anti-AAV Antibodies Published in Nature Medicine	AQ
17/12/19	SPARK THERAPEUTICS, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	AQ
17/12/19	Spark Therapeutics : Roche and Spark Therapeutics, Inc. announce closing of investigation and unconditional clearance by the FTC	AQ
25/10/19	Spark Therapeutics Wins Prix Galien USA Award for LUXTURNA® (voretigene neparvovec-rzyl) as Best Biotechnology Product	GL
18/09/19	Paralympic Skier Danelle Umstead Teams Up with Spark Therapeutics to Help People Living with Inherited Retinal Diseases (IRDs) Access Genetic Testing	GL

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Articles Zonebourse Analyses Zonebourse

Filtres

Tous les transcripts sur plus de 9000 sociétés, le jour de leur publication !

Débloquez-les Maintenant !

Débloquez-les Maintenant !